Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on May 11, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Artificial Intelligence and Computational Statistics Platform for Biosimilar Subvisible Characterization

Closed
FDA-75F40126Q00142Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 513210
New
Federal
NIH NIAID Genedata Analyst bioinformatics software program
Solicitation # 7571TE26Q00254
The Department of Health and Human Services, through the Office of Mission Acquisition Solutions on behalf of the National Institute of Allergy and Infectious Diseases, intends to award a firm-fixed-price contract to Genedata (USA), Inc. for a 12-month renewal of the Genedata Analyst bioinformatics software. This software is essential for the Viral Pathogenesis and Evolution Section to perform statistical modeling of multi-omics data, including genomics, transcriptomics, and proteomics, to support research on respiratory viral diseases and the development of vaccines and therapies. The requirement is being pursued as a single-source procurement under FAR Part 12 and FAR Part 6.103-1, as the software is critical for maintaining continuity with over 100 million historical gene-expression data points and established analytical workflows. Genedata Analyst provides comprehensive capabilities for data normalization using methods such as LOWESS and Quantile Normalization, as well as advanced statistical tools including mixed linear models, Principal Components Analysis, and various parametric and non-parametric tests. The software also incorporates machine learning tools like Decision Trees and Partial Least Square analysis, alongside interactive visualization features such as heat maps and scatter plots. Interested parties may submit capability statements by September 14, 2026, to demonstrate the ability to provide an equivalent solution that maintains compatibility with existing research data and workflows without disrupting ongoing scientific activities.
Omas Strategic Buying Center - Information Technology

POSTED

about 12 hours ago

DEADLINE

in 3 days
NAICS: 513210
New
SLED
ZenGRC Subscription Renewal
Solicitation # 2027-IFB-00079
The Technology Services Department of San Mateo County is seeking a qualified, responsible, and manufacturer-authorized vendor to renew its ZenGRC subscription for a three-year term. The period of performance is divided into three annual cycles starting February 1, 2027, and ending January 31, 2030. The primary requirement is the ZenGRC platform subscription with annualized payments, though the County may optionally include the ZenGRC Policy Suite and Trust Center Bundle depending on budget availability. The contract will be awarded to the lowest responsive bid, with evaluations based on the total bid price for the base subscription and a total lump-sum cost for the optional bundle. Bidders must be registered and active in the System for Award Management and provide a Unique Entity ID. Submissions are due by September 22, 2026, via the OpenGov portal and must include a formal quotation, a current W-9, and a SAM report. The contract requires adherence to California tax changes effective January 1, 2027, regarding Software as a Service, and mandates a manufacturer warranty of at least one year. Additionally, vendors must certify they have no recent findings of discrimination and comply with equal employment opportunity and disability access standards. Payment will be processed based on the agreed-upon schedule, with final invoices paid within 30 calendar days of approval.
Technology Services

POSTED

1 day ago

DEADLINE

in 11 days
NAICS: 513210
New
SLED
| FaxPulse Lic Mnt Bundle | BWC270346 | FY27 | DB
Solicitation # SRC0000041792
This solicitation, identified as SRC0000041792, is issued by the Ohio Bureau of Workers' Compensation for the procurement of a FaxPulse Perpetual License, Maintenance, Install, and Training bundle for a twelve month period. This opportunity is restricted exclusively to Minority Business Enterprise MBE suppliers, with the award granted to the lowest responsive and responsible MBE bidder. In the event of a pricing tie, the contract will be awarded to the supplier who submitted their proposal first. The scope of work includes the acquisition of business intelligence and data analysis software, specifically requiring a FaxPulse BI Server perpetual license with up to four SUID licenses and ten Document CALs, one additional SUID license, and associated annual maintenance and premium support plans. Additionally, the contract covers installation and up to sixteen hours of training. All proposals must be submitted electronically via the OhioBuys platform by the September 16, 2026 deadline. Suppliers must adhere to the BWC Procurement Terms and Conditions effective October 2025, which include mandates regarding affirmative action verification for contracts over five thousand dollars, non-discrimination compliance, and prohibitions against the use of public funds for offshore services or Russian institutions.
Bwc300300 Infrastructure And Operations Wgbl

POSTED

1 day ago

DEADLINE

in 5 days
NAICS: 513210
New
SLED
Traffic Safety Software
Solicitation # 2026-RFP-108
The City of Lakeland, through its Public Works Traffic Operations department, is soliciting proposals under RFP 2026-RFP-108 for advanced traffic safety software. The objective is to acquire a solution capable of geospatial analysis, risk assessment to predict crash hotspots, and customizable reporting for city commission districts to improve road safety for drivers, pedestrians, and cyclists. The procurement requires a comprehensive technical proposal, a project implementation plan, and a cost breakdown covering annual subscription and maintenance fees along with a one-time integration fee. The city will award the contract based on the most responsive proposal, considering factors such as technical evaluation, experience, and qualifications rather than cost alone. The contract imposes strict technical and legal requirements, including adherence to the NIST Cybersecurity Framework, AES 256-bit encryption for data at rest, and TLS 1.2 or higher for data in transit. To ensure ethical and fair outcomes, the selected vendor must implement bias detection and correction mechanisms in their AI models and conduct regular audits. Compliance mandates include a Human Trafficking Affidavit, E-Verify certification, and a drug-free workplace certification. Furthermore, the contractor must agree to comprehensive indemnification terms and undergo safety audits to ensure compliance with OSHA standards and Florida statutes. Proposals must be submitted electronically via the OpenGov portal by October 1, 2026.
Public Works Traffic Operations

POSTED

1 day ago

DEADLINE

in 20 days

AI Contract Overview

Show more

The Food and Drug Administration’s Office of Product Quality Research is seeking a machine learning and computational statistics platform to detect and classify protein aggregates in biosimilar drug products, supporting a feasibility study on AI and statistical methods for biosimilar comparability, quality assessment, and surveillance. The platform must generate morphological fingerprints specific to product types and underlying stress mechanisms, differentiate particles originating from the product, stress conditions, or container closure system, and operate directly on Flow Imaging and Backgrounded Membrane Imaging data without pre-processing. It must integrate neural network-based metric learning and computational statistics to characterize subvisible particles under 100 microns, predict root causes of particle formation, and provide quantitative data beyond basic size and count metrics, using advanced statistical tools such as Euclidean distance and Kolmogorov-Smirnov similarity scores. The system must be capable of compensating for optical artifacts across scales, allow visual review of the twenty nearest images to any fingerprint point, and demonstrate prior peer-reviewed success in applying supervised and unsupervised machine learning to classify biological particle images. Training must be provided to FDA staff on using the platform for quality analysis. The contract will be awarded as a fixed-price, lowest price technically acceptable (LPTA) award, with technical conformance being a mandatory pass/fail threshold; any failure to meet a requirement renders the quote technically unacceptable regardless of price. Only technically acceptable offers will be compared on price, with the lowest priced qualifying offer selected. The platform must be commercially available and accepted within the biopharmaceutical industry. The performance period is 12 months from contract award, with delivery and acceptance occurring at the FDA’s Center for Drug Evaluation and Research in Silver Spring, Maryland. The contractor must ensure all Information and Communication Technology, including the platform and associated documentation, complies with Section 508 accessibility standards, submitting an Accessibility Conformance Report using the VPAT Version 2.0, and must provide an invoice log addendum. Submission must be via email to the Contract Specialist by May 26, 2026, using Microsoft Office formats with no macros permitted. The Unique Entity Identifier (UEI) must accompany the proposal. The contract incorporates numerous standard federal acquisition clauses covering labor standards, equal opportunity, trafficking in persons, pay transparency, privacy, Buy American provisions, supply chain security, ethical conduct, whistleblower protections, and prohibition of products from restricted entities like Kaspersky, ByteDance, and Huawei. Invoicing must occur through the Treasury’s Invoice Processing Platform. No set-aside

General Info

Machine learning platform needed for protein aggregate classification in biosimilars, fixed-price contract, deadline May 2026.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

Contract Value

$55,000

NAICS

513210 - Software PublishersView NAICS

Place of Performance

Silver Spring, MD, 20993, USA

Set-Aside

NONE

Awardee

SENTRYSCIENCES, INC.View Profile

Award Issued Date

Documents

(1)

RFQ FDA-75F40126Q00142 Artificial Intelligence Platform for Biosimilar Characterization

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Combined Synopsis

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
Contacts1 person available
OfficeRockville, MD, 20852, USA
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressRockville, MD, 20852, USA
Contacts

Full Description

Show more

The Food and Drug Administration’s Office of Product Quality Research (OPQR) require a machine learning (ML/AI) and computational statistics platform with associated services to detect and classify protein aggregates in biosimilar drug products. This capability will support a feasibility study assessing the utility of artificial intelligence/machine learning and computational statistical analysis for biosimilar comparability assessment, quality assessment, and quality surveillance.


The platform:
• Shall combine machine learning to generate morphological fingerprints of protein aggregates
• Shall generate morphological fingerprints specific to product and underlying stress or mechanism of aggregation
• Shall be able to differentiate particles from different stress types, the product, and container closure system.
• Shall combine computational statistics and neural network-based metric learning to characterize heterogeneous suspensions of subvisible particles (those <100 microns) in biologic and biosimilar drug products
• Shall be compatible with Flow Imaging and Backgrounded Membrane Imaging data with no prior requirement for image processing
• Shall combine computational statistics and neural network-based metric learning to characterize and predict potential root cause of particle formation in biosimilar drug products
• Shall provide quantitative data on the aggregate and particle population inherent in biopharmaceuticals as opposed to simple size and count method used to characterize particles in drug solutions.
• Shall employ statistical analysis tools such as Euclidian distance, similarity score based on the Kolmogorov-Smirnov test or superior statistical tool
• Shall be a trusted, acceptable model used by the biopharmaceutical industry
• Shall have demonstrable experience and prior publications in applying supervised and unsupervised machine learning approaches to classify visible and subvisible particle images in biologics
• Shall compensate for optical phenomenon at different length scales
• Shall allow visual examination of at least the twenty nearest images to any point selected on the Fingerprint.
• Training provided to DPQR staff on application of AI/ML for particle classification and interpretation of results from AI particle classification approaches for product quality analysis


The Government will award a contract resulting from this solicitation to the responsible quoter as a fixed‐price contract on the lowest price technically acceptable (LPTA) evaluation method. Award will be made on the basis of the lowest evaluated price meeting or exceeding the non‐cost factor (technical conformance to the requirements of the solicitation). The Quoter’s initial quotation shall contain the Quoter’s best terms from a price standpoint. Failure to demonstrate meeting any of the requirements will result in a rating of technically unacceptable and will not be considered for award.


The following factors shall be used to evaluate quotes:
• Total price.
• Technical features meeting/exceeding requirements specified.


For further details, please review the attached RFQ_FDA-75F40126Q00142 document.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human induced pluripotent stem cell (iPSC)-derived hindbrain organoid functional assay services. The project aims to support in vitro research evaluating drug-induced effects on respiratory-relevant neural circuits over an eighteen-month period of performance. The scope of work is divided into two primary components: the provision of human hindbrain organoids and associated culture materials through twelve scheduled deliveries to the FDA White Oak Campus, and the performance of functional characterization services at the contractor's laboratory. Functional characterization will utilize three-dimensional multi-electrode array (3D MEA) technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Deliverables include the delivery of 96 organoids in the first shipment followed by 48 organoids in subsequent deliveries, as well as raw data, analyzed data, analysis files, and comprehensive study reports. This acquisition is conducted as a commercial service under FAR Part 12, with the government restricting competition based on market research identifying OrganoTherapeutics SARL as the only source capable of meeting the complete requirement for both the specific organoid products and the associated functional assay services.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 12 hours ago

DEADLINE

in 6 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS